The development of the vaccine with scientists at Oxford University -- and their decision to make it available at cost -- has made the Anglo-Swedish firm a household name. Since announcing successful clinical trials and having the vaccine passed by regulators, the company has faced a spate of challenges.from World News Headlines, Latest International News, World Breaking News - Times of India
No comments:
Post a Comment